Sulayman D Dib-Hajj Selected Research

Sodium Channels (Sodium Channel)

10/2021	Mini-review - Sodium channels and beyond in peripheral nerve disease: Modulation by cytokines and their effector protein kinases.
1/2021	KCNQ variants and pain modulation: a missense variant in Kv7.3 contributes to pain resilience.
1/2020	Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
1/2020	Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain.
1/2020	Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
1/2020	Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia.
10/2019	Building sensory axons: Delivery and distribution of NaV1.7 channels and effects of inflammatory mediators.
1/2019	The Two Sides of NaV1.7: Painful and Painless Channelopathies.
1/2019	NaV 1.6 regulates excitability of mechanosensitive sensory neurons.
1/2019	Sodium Channels in Human Pain Disorders: Genetics and Pharmacogenomics.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sulayman D Dib-Hajj Research Topics

Disease

58	Pain (Aches) 01/2022 - 06/2005
28	Erythromelalgia (Erythermalgia) 01/2021 - 09/2004
18	Neuralgia (Stump Neuralgia) 01/2021 - 10/2003
10	Chronic Pain 01/2018 - 06/2005
6	Small Fiber Neuropathy 01/2020 - 11/2012
5	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 06/2014
5	Channelopathies 01/2019 - 06/2005
5	Paroxysmal Extreme Pain Disorder 01/2017 - 09/2008
4	Hyperalgesia 01/2020 - 02/2010
4	Painful Neuropathy 06/2014 - 09/2004
3	Congenital Pain Insensitivity 01/2020 - 06/2010
3	Brain Diseases (Brain Disorder) 05/2016 - 09/2014
3	Epilepsy (Aura) 09/2014 - 08/2010
2	Trigeminal Neuralgia (Tic Douloureux) 02/2021 - 01/2020
2	Multiple Sclerosis 01/2015 - 02/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015 - 02/2012
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2015 - 02/2012
2	Inflammation (Inflammations) 10/2013 - 11/2012
1	Acute Pain 01/2020
1	Nerve Degeneration 01/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2018
1	Kidney Calculi (Kidney Stone) 07/2018
1	Somatoform Disorders (Somatoform Disorder) 01/2017
1	Movement Disorders (Movement Disorder) 05/2016
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 07/2015
1	Guillain-Barre Syndrome 07/2015
1	Infantile Epileptic-Dyskinetic Encephalopathy 05/2015
1	Intellectual Disability (Idiocy) 05/2015
1	Ataxia (Dyssynergia) 01/2015
1	Polyneuropathies (Polyneuropathy) 01/2015
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 09/2014
1	Chronic Disease (Chronic Diseases) 01/2013
1	Burns 08/2012
1	Nervous System Diseases (Neurological Disorders) 03/2012
1	Anosmia 05/2011
1	Self Mutilation 10/2010

Drug/Important Bio-Agent (IBA)

61	Sodium Channels (Sodium Channel)IBA 10/2021 - 10/2003
29	Voltage-Gated Sodium ChannelsIBA 01/2020 - 08/2004
8	Ion Channels (Ion Channel)IBA 10/2021 - 06/2005
7	Protein Isoforms (Isoforms)IBA 11/2020 - 04/2009
6	Carbamazepine (Tegretol)FDA LinkGeneric 11/2018 - 06/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 10/2010
5	Sodium Channel BlockersIBA 01/2019 - 10/2009
4	Tetrodotoxin (Tetradotoxin)IBA 11/2020 - 09/2004
4	SodiumIBA 01/2020 - 06/2010
3	Analgesics (Analgesic Drugs)IBA 11/2020 - 01/2017
3	Amino Acids FDA Link 05/2016 - 11/2006
2	Lacosamide FDA Link 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 02/2010
1	Scorpion Venoms (Scorpion Venom)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 10/2021
1	CytokinesIBA 10/2021
1	Menthol FDA Link 02/2021
1	CationsIBA 02/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	CannabinoidsIBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	benzothiazoleIBA 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2020
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	DexpramipexoleIBA 01/2020
1	RimonabantIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	SR 144528IBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 01/2019
1	CarrageenanIBA 01/2017
1	Aspartic Acid (Aspartate)FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	AutoantibodiesIBA 07/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2015
1	Arginine (L-Arginine)FDA Link 06/2015
1	6- amino- 5- (2,3,5- trichlorophenyl)pyridine- 2- carboxylic acid methylamideIBA 01/2015
1	Nodal ProteinIBA 01/2015
1	AntibodiesIBA 01/2015
1	Mutant Proteins (Protein, Mutant)IBA 11/2014
1	Lamotrigine (Lamictal)FDA LinkGeneric 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 09/2014
1	Messenger RNA (mRNA)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2013
1	Nerve Growth Factor (NGF)IBA 10/2013
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Peptides (Polypeptides)IBA 04/2012
1	EnzymesIBA 04/2012
1	Leucine (L-Leucine)FDA Link 07/2011

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2009
8	Drug Therapy (Chemotherapy) 01/2021 - 01/2010
1	Analgesia 01/2020
1	Anesthesia 01/2018
1	Precision Medicine 01/2018
1	Oral Administration 01/2015
1	Complementary Therapies (Alternative Medicine) 08/2014
1	Intradermal Injections 10/2013
1	Operative Surgical Procedures 01/2013